Bharat Biotech gets WHO prequalification for ROTAVAC 5D
WHO prequalification enables the procurement of ROTAVAC 5D by UN agencies namely UNICEF and PAHO
WHO prequalification enables the procurement of ROTAVAC 5D by UN agencies namely UNICEF and PAHO
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
Oxygen Park is a concept where a two-layer layout is being used to plant oxygen releasing trees which releases oxygen for 24 hours
The company has posted net profit of Rs.12.12 crores for the 12 months period ended March 31, 2021
It is expected that the drug substance would be available from August 2021 which will be supplied back to Bharat Biotech for producing COVAXIN
We focused on developing the product last year but now our focus is on ramping up our manufacturing capacity
Free cash flow also reached €63 million, representing an 11 percent increase compared to the high benchmark set in 2024
He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
Subscribe To Our Newsletter & Stay Updated